113 related articles for article (PubMed ID: 9129930)
1. Prognostic value of Ki-67 expression in renal cell carcinomas.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K
Eur Urol; 1997; 31(3):350-5. PubMed ID: 9129930
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.
Visapää H; Bui M; Huang Y; Seligson D; Tsai H; Pantuck A; Figlin R; Rao JY; Belldegrun A; Horvath S; Palotie A
Urology; 2003 Apr; 61(4):845-50. PubMed ID: 12670587
[TBL] [Abstract][Full Text] [Related]
3. Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer.
Aaltomaa S; Lipponen P; Vesalainen S; Ala-Opas M; Eskelinen M; Syrjänen K
Eur Urol; 1997; 32(4):410-5. PubMed ID: 9412797
[TBL] [Abstract][Full Text] [Related]
4. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.
Rioux-Leclercq N; Turlin B; Bansard J; Patard J; Manunta A; Moulinoux JP; Guillé F; Ramée MP; Lobel B
Urology; 2000 Apr; 55(4):501-5. PubMed ID: 10736491
[TBL] [Abstract][Full Text] [Related]
5. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma.
Bui MH; Visapaa H; Seligson D; Kim H; Han KR; Huang Y; Horvath S; Stanbridge EJ; Palotie A; Figlin RA; Belldegrun AS
J Urol; 2004 Jun; 171(6 Pt 1):2461-6. PubMed ID: 15126876
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma.
Yildiz E; Gokce G; Kilicarslan H; Ayan S; Goze OF; Gultekin EY
BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169
[TBL] [Abstract][Full Text] [Related]
8. [The clinical significance of immunohistochemically detectable Ki-67 protein in renal cell carcinoma].
Lazarev AF; Doroshenko VS; Varlamov SA
Vestn Ross Akad Med Nauk; 2007; (11):33-5. PubMed ID: 18080525
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma.
de Riese WT; Crabtree WN; Allhoff EP; Werner M; Liedke S; Lenis G; Atzpodien J; Kirchner H
J Clin Oncol; 1993 Sep; 11(9):1804-8. PubMed ID: 7689094
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma.
Rioux-Leclercq N; Epstein JI; Bansard JY; Turlin B; Patard JJ; Manunta A; Chan T; Ramee MP; Lobel B; Moulinoux JP
Hum Pathol; 2001 Nov; 32(11):1209-15. PubMed ID: 11727260
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
13. Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma.
Ebru T; Fulya OP; Hakan A; Vuslat YC; Necdet S; Nuray C; Filiz O
Int Braz J Urol; 2017; 43(3):440-454. PubMed ID: 27583351
[TBL] [Abstract][Full Text] [Related]
14. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
[TBL] [Abstract][Full Text] [Related]
15. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other.
Tollefson MK; Thompson RH; Sheinin Y; Lohse CM; Cheville JC; Leibovich BC; Kwon ED
Cancer; 2007 Aug; 110(4):783-90. PubMed ID: 17594714
[TBL] [Abstract][Full Text] [Related]
17. [Study of the prognostic value of DNA ploidy and proliferation index (Ki-67) in renal cell carcinoma with venous thrombus].
Rey D; Pfister C; Gobet F; Martinez S; Staerman F; Grise P
Prog Urol; 2003 Dec; 13(6):1300-6. PubMed ID: 15000303
[TBL] [Abstract][Full Text] [Related]
18. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
Delahunt B; Bethwaite PB; Thornton A; Ribas JL
Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
[TBL] [Abstract][Full Text] [Related]
19. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
20. Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma.
Gayed BA; Youssef RF; Bagrodia A; Darwish OM; Kapur P; Sagalowsky A; Lotan Y; Margulis V
BJU Int; 2014 Apr; 113(4):668-73. PubMed ID: 23937277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
